Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Shareholder Alert: Investigation over March 18, 2015 Secondary Offering
An investigation for shareholders who purchased shares ofValeant Pharmaceuticals Intl Inc (NYSE:VRX) in the March 18, 2015 Secondary Offering at $199.00 per share, was announced concerning over potential securities laws violations in connection with the March 18, 2015 Secondary Offering.
View full press release